RDTCF (Rapid Dose Therapeutics) 5-Year Share Buyback Ratio : -10.10% (As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Rapid Dose Therapeutics's current 5-Year Share Buyback Ratio was -10.10%.

RDTCF's 5-Year Share Buyback Ratio is ranked better than
55.56% of 1152 companies
in the Biotechnology industry
Industry Median: -12.45 vs RDTCF: -10.10

Competitive Comparison of Rapid Dose Therapeutics's 5-Year Share Buyback Ratio

For the Biotechnology subindustry, Rapid Dose Therapeutics's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's 5-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Rapid Dose Therapeutics 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Rapid Dose Therapeutics (OTCPK:RDTCF) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Rapid Dose Therapeutics 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.